Catheter Precision, Inc. (VTAK) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Catheter Precision, Inc. on August 25, 2023, regarding an event that occurred on August 22, 2023. The Company, formerly known as Ra Medical Systems, Inc., is incorporated in Delaware and its common stock trades on the NYSE American under the symbol "VTAK."
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on regulatory compliance status rather than financial performance data.
Material Changes
The primary material event reported is the Company's failure to comply with NYSE American continued listing standards. Specifically, the Company failed to timely file its Quarterly Report on Form 10-Q for the quarter ended June 30, 2023, by the extended due date of August 21, 2023. Consequently, the Company received a notice of non-compliance from NYSE Regulation on August 22, 2023, under Section 1007 of the NYSE American Company Guide.
Outlook, Risks, and Contingencies
The immediate risk identified is the potential delisting of the Company's common stock from the NYSE American due to the failure to meet timely filing criteria. The filing incorporates a press release issued on August 25, 2023, which details this notice. No forward-looking guidance or management commentary regarding future financial performance is included in this specific document.
Investor Verification Checklist
- Verify the current status of the Form 10-Q for the quarter ended June 30, 2023, to determine if it has since been filed.
- Review the Company's plan to regain compliance with NYSE American listing standards to avoid delisting.
- Check for any subsequent 8-K filings or press releases regarding the outcome of the delisting notice.
- Confirm the Company's current cash position and ability to fund operations given the regulatory distraction.